{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:10:01Z","timestamp":1751389801678,"version":"3.41.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Wear-induced osteolysis is a leading cause of late failure in total hip arthroplasty (THA). Denosumab, a RANKL inhibitor, suppresses osteoclast activity and may slow osteolytic progression. This feasibility study aimed to assess the practicality of conducting a randomized, double-blind, placebo-controlled trial evaluating Denosumab\u2019s effect on periprosthetic osteolysis in asymptomatic THA patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twelve patients were enrolled; ten completed follow-up. No significant difference in lesion volume change was observed between groups (Denosumab: +1.53\u00a0cm\u00b3; Placebo: +0.49\u00a0cm\u00b3). Secondary clinical outcomes also showed no notable differences. The trial protocol, recruitment, treatment, and follow-up were feasible, though slow enrollment limited statistical power. This study demonstrates the feasibility of a larger trial investigating Denosumab for osteolysis prevention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinicaltrails.gov, NCT02299817. Registered 20 November 2014. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT02299817?term=Denosumab%20for%20Treating%20Periprosthetic%20Osteolysis.%26;rank=1\" ext-link-type=\"uri\">https:\/\/www.clinicaltrials.gov\/study\/NCT02299817?term=Denosumab%20for%20Treating%20Periprosthetic%20Osteolysis.%26;rank=1<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13104-025-07216-0","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:56:19Z","timestamp":1744138579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Denosumab for treating periprosthetic osteolysis: a feasibility study"],"prefix":"10.1186","volume":"18","author":[{"given":"Michael","family":"Axenhus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Bod\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Kelly-Pettersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Sk\u00f6ldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"7216_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","volume":"370","author":"ID Learmonth","year":"2007","unstructured":"Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet. 2007;370:1508\u201319.","journal-title":"Lancet"},{"key":"7216_CR2","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1302\/0301-620X.89B7.18482","volume":"89","author":"CY Ng","year":"2007","unstructured":"Ng CY, Ballantyne JA, Brenkel IJ. Quality of life and functional outcome after primary total hip replacement. A five-year follow-up. J Bone Joint Surg Br. 2007;89:868\u201373.","journal-title":"J Bone Joint Surg Br"},{"key":"7216_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1054\/arth.2002.33664","volume":"17","author":"JH Dumbleton","year":"2002","unstructured":"Dumbleton JH, Manley MT, Edidin AA. A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty. 2002;17:649\u201361.","journal-title":"J Arthroplasty"},{"key":"7216_CR4","unstructured":"Harris WH. The problem is osteolysis. Clin Orthop Relat Res. 1995;:46\u201353."},{"key":"7216_CR5","doi-asserted-by":"crossref","unstructured":"Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop Relat Res. 2001;:66\u201370.","DOI":"10.1097\/00003086-200112000-00007"},{"key":"7216_CR6","first-page":"1","volume":"238","author":"L Ahnfelt","year":"1990","unstructured":"Ahnfelt L, Herberts P, Malchau H, Andersson GB. Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions. Acta Orthop Scand Suppl. 1990;238:1\u201326.","journal-title":"Acta Orthop Scand Suppl"},{"key":"7216_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/17453679308993679","volume":"64","author":"H Malchau","year":"1993","unstructured":"Malchau H, Herberts P, Ahnfelt L. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978\u20131990. Acta Orthop Scand. 1993;64:497\u2013506.","journal-title":"Acta Orthop Scand"},{"key":"7216_CR8","first-page":"1487","volume":"87","author":"S Kurtz","year":"2005","unstructured":"Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the united States from 1990 through 2002. J Bone Joint Surg Am. 2005;87:1487\u201397.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2106\/JBJS.H.00155","volume":"91","author":"KJ Bozic","year":"2009","unstructured":"Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the united States. J Bone Joint Surg Am. 2009;91:128\u201333.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.arth.2006.09.015","volume":"22","author":"DL Isaac","year":"2007","unstructured":"Isaac DL, Forder J, Skyrme AD, James SE. The biomet Bi-Metric total hip arthroplasty and universal acetabular cup: high polyethylene failure rate in the medium term. J Arthroplast. 2007;22:697\u2013700.","journal-title":"J Arthroplast"},{"key":"7216_CR11","doi-asserted-by":"crossref","unstructured":"Marshall A, Ries MD, Paprosky W, Implant Wear Symposium 2007 Clinical Work Group. How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000? J Am Acad Orthop Surg. 2008;16 Suppl 1:S1-6.","DOI":"10.5435\/00124635-200800001-00003"},{"key":"7216_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/jphp.12196","volume":"66","author":"GJ Leung","year":"2014","unstructured":"Leung GJ, Rainsford KD, Kean WF. Osteoarthritis of the hand I: aetiology and pathogenesis, risk factors, investigation and diagnosis. J Pharm Pharmacol. 2014;66:339\u201346.","journal-title":"J Pharm Pharmacol"},{"key":"7216_CR13","first-page":"1818","volume":"89","author":"DW Howie","year":"2007","unstructured":"Howie DW, Neale SD, Stamenkov R, McGee MA, Taylor DJ, Findlay DM. Progression of acetabular periprosthetic osteolytic lesions measured with computed tomography. J Bone Joint Surg Am. 2007;89:1818\u201325.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR14","doi-asserted-by":"publisher","first-page":"e1171","DOI":"10.2106\/JBJS.K.00877","volume":"94","author":"DW Howie","year":"2012","unstructured":"Howie DW, Neale SD, Martin W, Costi K, Kane T, Stamenkov R, et al. Progression of periacetabular osteolytic lesions. J Bone Joint Surg Am. 2012;94:e1171\u20131176.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2106\/00004623-199072020-00002","volume":"72","author":"RC Johnston","year":"1990","unstructured":"Johnston RC, Fitzgerald RH, Harris WH, Poss R, M\u00fcller ME, Sledge CB. Clinical and radiographic evaluation of total hip replacement. A standard system of terminology for reporting results. J Bone Joint Surg Am. 1990;72:161\u20138.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1302\/0301-620X.93B4.25868","volume":"93","author":"A L\u00fcbbeke","year":"2011","unstructured":"L\u00fcbbeke A, Garavaglia G, Barea C, Stern R, Peter R, Hoffmeyer P. Influence of patient activity on femoral osteolysis at five and ten years following hybrid total hip replacement. J Bone Joint Surg Br. 2011;93:456\u201363.","journal-title":"J Bone Joint Surg Br"},{"key":"7216_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.","journal-title":"BMC Med"},{"key":"7216_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377\u201381.","journal-title":"J Biomed Inf"},{"issue":"4 Suppl 2","key":"7216_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0049-0172(89)90010-3","volume":"18","author":"N Bellamy","year":"1989","unstructured":"Bellamy N. Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum. 1989;18(4 Suppl 2):14\u20137.","journal-title":"Semin Arthritis Rheum"},{"key":"7216_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2106\/00004623-196951040-00012","volume":"51","author":"WH Harris","year":"1969","unstructured":"Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737\u201355.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33:337\u201343.","journal-title":"Ann Med"},{"key":"7216_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2106\/00004623-200503000-00017","volume":"87","author":"S Leung","year":"2005","unstructured":"Leung S, Naudie D, Kitamura N, Walde T, Engh CA. Computed tomography in the assessment of periacetabular osteolysis. J Bone Joint Surg Am. 2005;87:592\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0736-0266(03)00093-7","volume":"21","author":"EM Schwarz","year":"2003","unstructured":"Schwarz EM, Campbell D, Totterman S, Boyd A, O\u2019Keefe RJ, Looney RJ. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res. 2003;21:1049\u201355.","journal-title":"J Orthop Res"},{"key":"7216_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"7216_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13018-018-1036-2","volume":"13","author":"MC Castano-Betancourt","year":"2018","unstructured":"Castano-Betancourt MC, Fruschein Annichino R, de Azevedo eS, Munhoz M, Gomes Machado E, Lipay MV, Marchi E. Identification of high-risk groups for complication after arthroplasty: predictive value of patient\u2019s related risk factors. J Orthop Surg Res. 2018;13:328.","journal-title":"J Orthop Surg Res"},{"key":"7216_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.arth.2023.08.078","volume":"39","author":"R Liukkonen","year":"2024","unstructured":"Liukkonen R, Honkanen M, Skytt\u00e4 E, Eskelinen A, Karppelin M, Reito A. Clinical outcomes after revision hip arthroplasty due to prosthetic joint Infection-A Single-Center study of 369 hips at a High-Volume center with a minimum of one year Follow-Up. J Arthroplasty. 2024;39:806\u2013e8123.","journal-title":"J Arthroplasty"},{"key":"7216_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.33549\/physiolres.931140","volume":"57","author":"J Gallo","year":"2008","unstructured":"Gallo J, Raska M, Mr\u00e1zek F, Petrek M. Bone remodeling, particle disease and individual susceptibility to periprosthetic osteolysis. Physiol Res. 2008;57:339\u201349.","journal-title":"Physiol Res"},{"key":"7216_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/jor.21135","volume":"28","author":"A Gordon","year":"2010","unstructured":"Gordon A, Greenfield EM, Eastell R, Kiss-Toth E, Wilkinson JM. Individual susceptibility to periprosthetic osteolysis is associated with altered patterns of innate immune gene expression in response to pro-inflammatory stimuli. J Orthop Res. 2010;28:1127\u201335.","journal-title":"J Orthop Res"},{"key":"7216_CR29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.blo.0000246531.59876.a8","volume":"453","author":"CT Talmo","year":"2006","unstructured":"Talmo CT, Shanbhag AS, Rubash HE. Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop Relat Res. 2006;453:254\u201364.","journal-title":"Clin Orthop Relat Res"},{"key":"7216_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2106\/JBJS.D.01772","volume":"87","author":"M Bhandari","year":"2005","unstructured":"Bhandari M, Bajammal S, Guyatt GH, Griffith L, Busse JW, Sch\u00fcnemann H, et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am. 2005;87:293\u2013301.","journal-title":"J Bone Joint Surg Am"},{"key":"7216_CR31","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.metabol.2015.07.011","volume":"64","author":"P Makras","year":"2015","unstructured":"Makras P, Delaroudis S, Anastasilakis AD. Novel therapies for osteoporosis. Metabolism. 2015;64:1199\u2013214.","journal-title":"Metabolism"},{"key":"7216_CR32","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361:756\u201365.","journal-title":"N Engl J Med"},{"key":"7216_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bone.2010.09.024","volume":"48","author":"P Aspenberg","year":"2011","unstructured":"Aspenberg P, Agholme F, Magnusson P, Fahlgren A. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. Bone. 2011;48:225\u201330.","journal-title":"Bone"},{"key":"7216_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/17453674.2013.854668","volume":"85","author":"E Drampalos","year":"2014","unstructured":"Drampalos E, Skarpas G, Barbounakis N, Michos I. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 2014;85:3\u20135.","journal-title":"Acta Orthop"},{"key":"7216_CR35","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00198-023-06869-6","volume":"34","author":"D Fitzpatrick","year":"2023","unstructured":"Fitzpatrick D, Seebah S, Lannon R, Mc Carroll K. Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate Na\u00efve patients: two further cases. Osteoporos Int. 2023;34:1807\u20138.","journal-title":"Osteoporos Int"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07216-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:55:13Z","timestamp":1751388913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7216"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07216-0","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Karolinska Institute and the Swedish Medical Products Agency approved the study. Individual consent was obtained from each patient. The trial is registered at ClinicalTrials.gov (NCT02299817), registered 20th of November 2014.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}